Clinical Trial Update: Comparing in Dexmedetomidine With po/pr Midazolam for Procedural Sedation in the Pediatric Emergency Department [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dexmedetomidine with oral/rectal midazolam for pediatric procedural sedation; study status withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emergencies
• Procedural Anxiety

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Midazolam (Midazolam)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Procedural Anxiety, Emergencies | Phase 4 | Status: WITHDRAWN